Risk factors, pre-morbid functioning and episode correlates of neurological soft signs in drug-naive patients with schizophrenia-spectrum disorders

Psychological Medicine

Volumn 41, Issue 6, 2011, Pages 1279-1289

  Peralta, V ^a   De Jalon E G ^a   Campos, M S ^a   Basterra, V ^a   Sanchez Torres, A ^a   Cuesta, M J ^a  

^a Universidad Pública de Navarra   (Spain)

Author keywords

Extrapyramidal symptoms; neurodevelopment; neurological soft signs; psychopathology; schizophrenia

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; COMORBIDITY; DELUSION; EXTRAPYRAMIDAL SYNDROME; FEMALE; HUMAN; MALE; MIDDLE AGED; NEUROLOGIC EXAMINATION; NEUROPSYCHOLOGICAL TEST; PARKINSONISM; PSYCHOLOGICAL ASPECT; PSYCHOLOGY; PSYCHOMETRY; PSYCHOSIS; RISK FACTOR; SCHIZOPHRENIA; SOCIAL ADAPTATION; STATISTICS;

ADOLESCENT; ADULT; BASAL GANGLIA DISEASES; COMORBIDITY; DELUSIONS; FEMALE; HUMANS; MALE; MIDDLE AGED; NEUROLOGIC EXAMINATION; NEUROPSYCHOLOGICAL TESTS; PARKINSONIAN DISORDERS; PSYCHOMETRICS; PSYCHOTIC DISORDERS; RISK FACTORS; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SOCIAL ADJUSTMENT; STATISTICS AS TOPIC; YOUNG ADULT;

EID: 79955995588     PISSN: 00332917     EISSN: 14698978     Source Type: Journal    
DOI: 10.1017/S0033291710001856     Document Type: Article

References (41)

1. Andreasen NC, Flaum M, Arndt S (1992). The Comprehensive Assessment of Symptoms and History (CASH): an instrument for assessing diagnosis and psychopathology. Archives of General Psychiatry 49, 615-623.
2. Arango C, Kirkpatrick B, Buchanan RW (2000). Neurological signs and the heterogeneity of schizophrenia. American Journal of Psychiatry 157, 560-565. (Pubitemid 30191194)
3. Bachman S, Bottmer C, Schröder J (2005). Neurological soft signs in first-episode schizophrenia. American Journal of Psychiatry 162, 2337-2343. (Pubitemid 41740213)
4. Barnes TRE (1989). A rating scale for drug-induced akathisia. British Journal of Psychiatry 154, 534-537.
5. Bombin I, Arango C, Buchanan RW (2005). Significance and meaning of neurological soft signs in schizophrenia: two decades later. Schizophrenia Bulletin 31, 962-977. (Pubitemid 41437791)
6. Browne S, Clarke M, Gervin M, Lane A, Waddington JL, Larkin C, O'Callaghan E (2000). Determinants of neurological dysfunction in first episode schizophrenia. Psychological Medicine 30, 1433-1441.
7. Buchanan RW, Heinrichs DW (1989). The Neurological Evaluation Scale (NES): a structured instrument for the assessment of neurological signs in schizophrenia. Psychiatry Research 27, 335-350. (Pubitemid 19096791)
8. Cannon M, Jones P, Gilvarry C, Rifkin L, McKenzie K, Foerster A, Murray RM (1997). Premorbid social functioning in schizophrenia and bipolar disorder: similarities and differences. American Journal of Psychiatry 154, 1544-1550. (Pubitemid 27471347)
9. Cannon M, Tarrant CJ, Huttunen MO, Jones P (2009). Childhood development and later schizophrenia: evidence from genetic high-risk and birth cohort studies. In The Epidemiology of Schizophrenia (ed. R. M. Murray, P. B. Jones, E. Susser, J. van Os and M. Cannon), pp. 100-123. Cambridge University Press: Cambridge, UK.
10. Chan RZK, Gottesman II (2008). Neurological soft signs as candidate endophenotypes for schizophrenia: a shooting star or Northern star? Neuroscience and Behavioral Reviews 32, 957-971.
11. Chan RZK, Xu T, Heinrichs W, Yu Y, Wang Y (2009). Neurological soft signs in schizophrenia: a meta-analysis. Schizophrenia Bulletin. Published online: 17 April 2009. doi :10.1093/schbul/sbp011.
12. Chen EYH, Kwok CL, Au JWY, Chen RYL, Lau BST (2000). Progressive deterioration of soft neurological signs in chronic schizophrenic patients. Acta Psychiatrica Scandinavica 102, 342-349.
13. Compton MT, Bercu Z, Bollini A, Walker E (2006). Factor structure of the Neurological Assessment Scale in predominantly African American sample of patients with schizophrenia, unaffected relatives, and non-psychiatric controls. Schizophrenia Research 84, 365-377.
14. Cuesta MJ, Peralta V, Zarzuela A, Calvo R, García M, Serrano F (2002). Neurological soft signs in psychosis: threshold criteria for discriminating normal controls and for predicting cognitive impairment. Schizophrenia Research 58, 263-271. (Pubitemid 35284518)
15. Dazzan P, Lloyd T, Morgan KD, Zanelli J, Morgan C, Orr K, Hutchinson G, Fearon P, Allin M, Rifkin L, McGuire PK, Doody GA, Holloway J, Leff J, Harrison G, Jones PB, Murray RM (2008). Neurological abnormalities and cognitive ability in first-episode psychosis. British Journal of Psychiatry 193, 197-202.
16. Dazzan P, Morgan KD, Orr KG, Hutchinson G, Chitnis X, Suckling J, Fearon P, Salvo J, McGuire PK, Mallet RM, Jones PB, Leff J, Murray RM (2004). The structural brain correlates of neurological soft signs in AESOP first-episode psychoses study. Brain 127, 143-153. (Pubitemid 38055353)
17. Dazzan P, Murray RM (2002). Neurological soft signs in first-episode psychosis: a systematic review. British Journal of Psychiatry 181, 50-57.
18. Goldstein G, Sanders RD, Forman SD, Tarpey T, Gurklis JA, Van Kammen DP, Keshavan MS (2005). The effects of antipsychotic medication on factor structure of neurological examination abnormalities in schizophrenia. Schizophrenia Research 75, 55-64. (Pubitemid 40487974)
19. Griffiths TD, Sigmundsson T, Takei N, Rowe D, Murray RM (1998). Neurological abnormalities in familial and sporadic schizophrenia. Brain 121, 191-203. (Pubitemid 28075797)
20. Gupta S, Andreasen NC, Arndt S, Flaum M, Schultz S, Hubbard WC, Smith M (1995). Neurological soft signs in neuroleptic-naive and neuroleptic treated schizophrenic patients and normal comparison subjects. American Journal of Psychiatry 152, 191-196.
21. Guy W (1976). ECDEU Assessment Manual for Psychopharmacology. Publication no. ADM 76-338, pp 534-537. US Department of Health, Education, and Welfare: Washington, DC.
22. Heinrichs DW, Buchanan RW (1988). Significance and meaning of neurological signs in schizophrenia. American Journal of Psychiatry 145, 11-18. (Pubitemid 18025646)
23. Janssen J, Diaz-Caneja A, Reig S, Bombín I, Mayoral M, Parellada M, Graell M, Moreno D, Zabala A, Vázquez VG, Desco M, Arango C (2009). Brain morphology and neurological soft signs in adolescents with first-episode psychosis. British Journal of Psychiatry 195, 227-233.
24. Jones P, Rodgers B, Murray RM, Marmot M (1994). Child developmental risk factors for adult schizophrenia in the British 1946 birth cohort. Lancet 344, 1398-1402. (Pubitemid 24365314)
25. Keshavan MS, Sanders RD, Sweeney JA, Diwadkar VA, Goldstein G, Pettegrew JW, Schooler NR (2003). Diagnostic specificity and neuroanatomical validity of neurological abnormalities in first-episode psychoses. American Journal of Psychiatry 160, 1298-1304. (Pubitemid 41070947)
26. Krebs MO, Gut-Fayand A, Bourdel M-C, Dischamp J, Olié JP (2000). Validation and factorial structure of a standardized neurological examination assessing neurological soft signs in schizophrenia. Schizophrenia Research 45, 245-260.
27. Madsen AL, Vorstrup S, Rubin P, Larsen JK, Hemmingsen R (1999). Neurological abnormalities in schizophrenic patients: a prospective follow-up study 5 years after first admission. Acta Psychiatrica Scandinavica 100, 119-125. (Pubitemid 29372528)
28. McNeil TF, Sjöström K (1995). McNeil-Sjöström Scale for Obstetric Complications. Lund University Department of Psychiatry, Malmö University Hospital: Malmö, Sweden.
29. Peralta V, Cuesta MJ (2001). How many and which are the psychopathological dimensions in schizophrenia? Issues influencing their ascertainment. Schizophrenia Research 49, 269-285. (Pubitemid 32453228)
30. Peralta V, Cuesta MJ, Serrano JF (2006). Obstetric complications and neurological abnormalities in neuroleptic-näýve psychotic patients. European Archives of Psychiatry and Clinical Neurosciences 256, 407-413. (Pubitemid 44584056)
31. Picchioni MM, Toulopoulou R, Landau S, Davies N, Ribchester T, Murray RM (2006). Neurological abnormalities in schizophrenia twins. Biological Psychiatry 59, 341-348.
32. Sanders RD, Allen DN, Forman SD, Tarpey T, Keshavan M, Goldstein G (2005). Confirmatory factor analysis of the Neurological Evaluation Scale in unmedicated schizophrenia. Schizophrenia Research 133, 65-71. (Pubitemid 40215472)
33. Scheuerecker J, Ufer S, Käpernick M, Wiesman M, Brückmann H, Kraft E, Seifert D, Koutsouleris N, Möller HJ, Meisenzahl EM (2008). Cerebral network deficits in post-acute catatonic schizophrenic patients measured by fMRI. Journal of Psychiatric Research 43, 607-614.
34. Simpson GM, Angus JW (1970). A rating scale for extrapyramidal side effects. Acta Psychiatrica Scandinavica 212, 11-19.
35. Thomann PA, Wüstenberg T, Dos Santos V, Bachman S, Essig M, Schröder J (2009). Neurological soft signs and brain morphology in first-episode schizophrenia. Psychological Medicine 39, 371-379.
36. Tosato S, Dazzan P (2005). The psychopathology of schizophrenia and the presence of neurological soft signs: a review. Current Opinion in Psychiatry 18, 285-288. (Pubitemid 40586112)
37. Verdoux H, van Os J, Sham P, Jones P, Gilvarry K, Murray RM (1996). Does familiality predispose to both emergence and persistence of psychosis? A follow-up study. British Journal of Psychiatry 168, 620-626.
38. Ward MF, Wender PH, Reimherr FW (1993). The Wender Utah Rating Scale: an aid in the retrospective diagnosis of childhood attention deficit hyperactivity disorder. American Journal of Psychiatry 150, 885-890. (Pubitemid 23156767)
39. Whitty P, Clarke M, Browne S, McTigue O, Kamali M, Feeney L, Lane A, Kinsella A, Waddington JL, Larkin C, O'Callaghan E (2003). Prospective evaluation of neurological soft signs in first-episode schizophrenia in relation to psychopathology: state versus trait phenomena. Psychological Medicine 33, 1479-1484. (Pubitemid 37483471)
40. Whitty P, Clarke M, McTigue O, Browne S, Gervin M, Kamali M, Lane A, Kinsella A, Waddington JL, Larkin C, O'Callaghan E (2006). Diagnostic specificity and predictors of neurological soft signs in schizophrenia, bipolar disorder and other psychoses over the first 4 years of illness. Schizophrenia Research 86, 110-117. (Pubitemid 44234035)
41. Whitty P, Owoeye O, Waddington J (2009). Neurological signs and involuntary movements in schizophrenia : intrinsic to and informative on systems pathobiology. Schizophrenia Bulletin 35, 415-424.